Francesca Bizzaro

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice.

Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice.

Journal: Antioxidants & redox signaling

Published: November 15, 2021

Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.

Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.

Journal: International journal of cancer

Published: September 11, 2021

VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.

VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.

Journal: Journal of hematology & oncology

Published: August 04, 2021

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.

Journal: Oncotarget

Published: January 29, 2018

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.

Journal: International journal of cancer

Published: December 20, 2017

Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer.

Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer.

Journal: Cancer research

Published: April 19, 2017

Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics.

Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics.

Journal: Chinese journal of cancer

Published: April 12, 2016

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Journal: Connective tissue research

Published: May 07, 2015

Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.

Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.

Journal: Clinical & experimental metastasis

Published: November 27, 2014

Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.

Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.

Journal: Cancer research

Published: October 12, 2014

Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents.

Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents.

Journal: Frontiers in oncology

Published: July 17, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026